Such metabolomics network has already been created for thyroid hormone secretion pathway, which helped to identify the potential drug targets essential in treatment of thyroid disorders such as hypo- or hyperthyroidism [133, 134]. This evidence concerns the gene TG and thyroid gland disorder.